Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

In recent years, the microbiome has made a transformation from “obscure to ubiquitous”. Numerous studies have tentatively associated the whole range of microorganisms that live inside us with our immune, bodily, and even mental health. From how well we respond to cancer treatments (or indeed how vulnerable we are to cancer), from whether or not we suffer from inflammatory bowel disorders or autistic spectrum disorders, to how gracefully we age, microbiome studies claims insider knowledge.

This vogue has not only caught the scientific imagination, but also the popular one. Books on the subject abound, from popular science, such as Ed Yong’s I Contain Multitudes and Rodney Dietert’s The Human Superorganism, to diet books including Michael Mosley’s The Clever Guts Diet.

The problem with the lure of the microbiome is that the correlations that underpin these studies are much more complicated than simple cause and effect. Such relationships can be very misleading. The number of people who drowned by falling into a pool in the US in period 1999-2009, for example, correlates bizarrely well with the number of films that Nicholas Cage appeared in across the same ten year period. But we don’t tend to argue that one causes the other.

While microbiome studies promises genuine advances in many fields, it is, as Harvard professor of epidemiology William Hanage notes, in danger of “being drowned in a tsunami of its own hype”. Other promising emergent fields, like epigenetics, simply haven’t entered the popular sphere with anything like so much drama or success. So why does the microbiome hold so much cultural currency? 

Read the full article on The Conversation website, written by Emilie Taylor-Brown, Postdoctoral Research Assistant in the Faculty of English Language and Literature. Oxford is a subscribing member of The ConversationFind out how you can write for The Conversation.

 

Similar stories

Oxford-led team given £6.6m to map uncharted networks in the progression of Parkinson’s

A major new $9 million (£6.6 million) project funded by the Aligning Science Across Parkinson’s (ASAP) initiative will map the original circuits vulnerable to Parkinson’s on an unprecedented scale. It is the only UK-led ASAP project this year, and the first ever to be led by Oxford.

Tamoxifen repurposing study shows no benefit in treating deadly fungal meningitis

Hopes that tamoxifen could improve survival for a deadly form of fungal meningitis have been dashed by the results of a clinical trial conducted by University of Oxford researchers and published today in eLife.

Oxford researchers awarded funding to complete community COVID-19 antiviral trial

Researchers from the Nuffield Department of Primary Care Health Sciences, University of Oxford, have today announced that they have been awarded funding through the National Institute for Health Research (NIHR) to work with several UK universities and carry out a first-of-its-kind clinical trial, testing novel antiviral COVID-19 treatments for use early on in the illness by people in the community with COVID-19 who are at higher risk of complications.

New therapeutic targets identified to treat inflammatory bowel disease

Millions of patients with ulcerative colitis or Crohn’s disease, collectively known as inflammatory bowel disease (IBD), are given fresh hope as a new study shows why some of them do not respond to current treatments.

Oxford researchers call for an urgent re-evaluation of “weak” opioid safety profile

A new study associates dispensation doses of tramadol with increased risk of mortality, cardiovascular events, and fractures compared to the use of codeine to treat pain.

Labelling proteins through the diet gives new insights into how collagen-rich tissues change as we age

A new study, published in eLife, uses advanced tissue analysis technology to show how the incorporation of new proteins changes in bone and cartilage with age.